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Abstract
Background: Impact factor (IF) is a commonly used surrogate for assessing the scientific quality of journals and articles.
There is growing discontent in the medical community with the use of this quality assessment tool because of its many
inherent limitations. To help address such concerns, Eigenfactor (ES) and Article Influence scores (AIS) have been devised to
assess scientific impact of journals. The principal aim was to compare the temporal trends in IF, ES, and AIS on the rank
order of leading medical journals over time.
Methods: The 2001 to 2008 IF, ES, AIS, and number of citable items (CI) of 35 leading medical journals were collected from
the Institute of Scientific Information (ISI) and the http://www.eigenfactor.org databases. The journals were ranked based on
the published 2008 ES, AIS, and IF scores. Temporal score trends and variations were analyzed.
Results: In general, the AIS and IF values provided similar rank orders. Using ES values resulted in large changes in the rank
orders with higher ranking being assigned to journals that publish a large volume of articles. Since 2001, the IF and AIS of
most journals increased significantly; however the ES increased in only 51% of the journals in the analysis. Conversely, 26%
of journals experienced a downward trend in their ES, while the rest experienced no significant changes (23%). This
discordance between temporal trends in IF and ES was largely driven by temporal changes in the number of CI published by
the journals.
Conclusion: The rank order of medical journals changes depending on whether IF, AIS or ES is used. All of these metrics are
sensitive to the number of citable items published by journals. Consumers should thus consider all of these metrics rather
than just IF alone in assessing the influence and importance of medical journals in their respective disciplines.
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Introduction
The impact factor (IF), which is a score calculated each year by
the Institute for Scientific Information (ISI), is widely considered as
one of the leading proxies for evaluating the quality, importance,
and influence of medical journals to their respective discipline
(Science Citation Index, Journal Citation Report. Institute for
Scientific Information, www.isinet.com). [1] Medical editors
frequently use the IF as a performance index of their journal
and a means of ranking their journals relative to their
peers.[2,3,4,5] Some journals use the IF to ‘‘advertise’’ their
quality and to entice potential authors in submitting high-quality
papers to them. Promotion committees of academic institutions
commonly use the IF to judge the quality of publications of
applicants for promotion and tenure and departmental chairs may
use it in the hiring and assessment process of new recruits. [6]
Increasingly, however, there is growing discontent with the IF as a
tool for determining ‘‘quality’’ and ‘‘prestige’’ of journals [7,8].
One reason is that the distribution of citations is non-parametric
with fewer than 20% of the articles accounting for more than 50%
of the total number of citations of journals and with many articles
that never receive any citations [9,10]. Moreover, IF only counts
the number of citations without taking into account the source of
the citations (ie. citations from prestigious journals are worth no
more than citations from lower-tier journals) or makes any
allowances for the ‘‘citation culture’’ between journals and across
disciplines [7]. It is also now well recognized that journal’s IF can
be increased by reducing the number of original research papers
and increasing the number of editorials (which are not counted in
the denominator of IF), review papers, which receive on average
twice as many citations as original articles [9,11] and by
encouraging self-citations [7,11]. Original research papers,
however, are the main ‘‘engines’’ of generating new knowledge
and, by decreasing their publication rate, journals may be
mitigating dissemination of scientific knowledge and curtailing
scientific discourse. Over time, this may increase the IF but
paradoxically reduce the overall influence of these journals on the
scientific community as fewer scientists and clinicians read the
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instruments including those that take into account the quality as
well as the quantity of citations, have been proposed [12,13,14].
This concept was first proposed by Pinski and Narin [15], who
suggested that journals should be ranked according to their
eigenvector centrality in a citation network. With the recent
success of Google’s ranking system for web pages, this concept has
been modified to include algorithms based on a PageRank system
[13]. Although there are several different algorithms in use, the
two that have gained the most attention in recent years are
Scimago Journal Rank (SJR) (http://www.scimagojr.com/index.
php) and Eigenfactor score (ES) (http://eigenfactor.org/), both of
which use an iterative weighting system to calculate a summary
index that reflects both the ‘‘quality’’ and the ‘‘quantity’’ of
citations received by these journals based on a PageRank
algorithm [12,15]. Despite the differences in the way in which
weight-based and non-weight based methods are derived, studies
have shown that in any given year, scores based on a PageRank
algorithm correlate well with those based on traditional IF and
produce similar rank order of medical journals [14,16]. However,
it is not known whether the temporal trends in these scores
produce similar or differential rank orders of these journals. Since
ES is at least in part dependent on the number of citable items
published by journals in any given year [17,18], by reducing the
publication rate, it is possible for a journal to increase IF without
changing its ES (and vice versa). Thus, the primary aim of the
present study was to determine the changes in IF and ES across
the major general and sub-specialty medical journals over the past
8 years.
Methods
Selection of Journals
We decided a priori to evaluate the temporal trends in the impact
factor (IF) and Eigenfactor Score (ES) in 35 general and
subspecialty clinical journals between 2001 and 2008. We chose
this timeframe to mitigate the influence of name changes of
journals in the IF and ES calculations and to ensure comparability
of data across the journals. To ensure reasonable representation of
journals from each discipline, we chose the three mostly highly
ranked journals per discipline as determined by the 2008 IF except
for respiratory medicine and endocrinology in which four rather
than three journals were selected. We did this to mitigate the
potential effect of overlap of content and audience of journals in
the ‘‘respiratory system’’ and ‘‘critical care medicine’’ (e.g. the
American Journal of Respiratory and Critical Medicine is listed both
categories) and to ensure that there is adequate representation of
non-diabetic papers (and audience) in ‘‘endocrinology’’ as the top
two journals under this category were diabetes-focused (e.g.
Diabetes and Diabetes Care). From the Thompson Reuters’ Journal
Citation Reports (http://admin-apps.isiknowledge.com/JCR/
JCR?PointOfEntry=Home&SID=3EIG4M34Amad@6eKDPA)
and the Eigenfactor.org websites (http://eigenfactor.org/), two
independent reviewers (JR, DS) abstracted data on the IF, ES,
citable items and Article Influence Score (AIS) on these journals.
The data were imported into an Excel Spreadsheet and any
disagreements were resolved by iteration and consensus.
T h ej o u r n a l st h a tw e r ee v a l u a t e di n c l u d e dAnnals of Neurology
(Ann Neurol), Annals of the Rheumatic Diseases (Ann Rheum Dis),
Arthritis and Rheumatism (Art Rheum/Ar C Res), Brain, Circulation,
Clinical Infectious Diseases (Clin Inf Dis), Diabetes, Diabetes Care,
European Heart Journal (Eur Heart J), Gastroenterology, Gut,
Hepatology, Intensive Care Medicine (Intens Care Med), Journal of the
American Medical Association (JAMA), Journal of American College of
Cardiology (J Am Coll Cardiol), Journal of Bone and Mineral Research (J
Bone Miner Res); Journal of Clinical Endocrinology and Metabolism (J
Clin Endocr Metab), Journal of Clinical Oncology (J Clin Oncol),
Journal of Infectious Diseases (J Infect Dis), Journal of the National
Cancer Institute (J Natl Cancer I), Journal of Neurosciences (J Neurosci),
Lancet, Lancet Infectious Diseases (Lancet Infect Dis), Lancet Oncology
(Lancet Oncol), New England Journal of Medicine (N Engl J Med),
Rheumatology, Allergy, American Journal of Respiratory and Critical Care
Medicine (Am J Respir Crit Care Med), Clinical and Experimental
Allergy (Clin Exp Allergy), Chest, Critical Care, Critical Care Medicine
(Crit Care Med), European Respiratory Journal (Eur Resp J), Journal of
Allergy and Clinical Immunology (J Allergy Clin Immunology),a n d
Thorax. We did not include any non-clinical journals.
Impact Factor
The IF is published by ISI each year for all indexed journals and
is calculated based on a three-year period. It reflects the average
number of times that papers are cited up to two years following
publication. For example, the 2009 IF for a journal would be
calculated by taking the number of times articles (original, reviews,
proceedings or notes) published in 2007 and 2008 were cited in
2009 and dividing this number by the total number of articles,
reviews, proceedings, guidelines or consensus statements that were
published in this journal in 2007 and 2008. Editorials and letters to
the editors are generally excluded from the denominator but can
be counted in the numerator of the impact factor. In general,
review articles, consensus statements and clinical guidelines are
cited more frequently than original articles[19].
Eigenfactor Score (ES)
For each of these journals, we retrieved data on the ES from
http://www.eigenfactor.org. ES is calculated based on a complex
algorithm that takes into account not only the quantity of citations
but also their ‘‘quality’’ by assigning weights to the source of the
citations. The full details of the algorithm can be found at http://
www.eigenfactor.org/methods.htm. In brief, the algorithm assigns
quality scores to journals by creating a citation network in which
journal articles are first randomly selected. The citation lists from
these retrieved articles are then used by the network to select the
next set of journals. The citation lists from this batch of journals
are then used by the network to select the third set of journals.
This process continues indefinitely creating a hierarchical ranking
of journals based on the frequency of citations. The network
assumes that journals that are highly cited are to be of high quality,
while those that are infrequently cited are deemed to be of lower
quality. Importantly, the ES has no denominator. Thus, journals
that publish a lot of articles have higher ES than those that publish
very few articles if the average quality of the published articles is
similar between these journals.
Article Influence Score (AIS)
Article Influence
TM Score (AIS) is derived from ES and
conceptually similar to IF in that there is a numerator as well as
a denominator (i.e. number of citable papers) except that it uses ES
(rather than the total number of citations) as the numerator. Thus,
dissimilar to IF where all citations are counted equally regardless
of their source, in AIS, each citation is multiplied by the ‘‘quality’’
of the citing journals, resulting in greater weights for citations that
come from highly cited journals, and less weight to poorly cited
journals. To facilitate interpretation, the AIS is normalized, so that
the mean article in the Journal of Citation ReportsH has an AIS of
1.00.
Impact Factor
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The journals were ranked based on the published 2008 ES, AIS,
and IF scores. We also retrieved the 2001 to 2008 ES, AIS, IF
scores, and number of citable items (CI) in order to determine the
temporal trends in these values. The statistical significance of the
temporal trends was determined using a chi-square test for trend.
A p-value of less than 0.05 was considered statistically significant.
All analyses were conducted using SAS version 9.1 (Carey, N.C.).
Results
2008 AIS, IF, and ES
The 2008 ES, AIS, and IF values of selected medical journals
are shown in Table 1. Of the evaluated journals, the overall leader
was the New England Journal of Medicine irrespective of the metric
used to measure quality. However, the rankings for the remaining
journals changed depending on the score that was used. For
instance, using the traditional IF score, the 2
nd leading journal in
2008 was JAMA, followed by the Lancet, J Clin Oncol and J Natl
Cancer I. In general, the AIS and IF values provided similar rank
orders, with few notable exceptions including J Neurosci, which was
ranked 11
th based on AIS and 20
th based on IF and J Allergy Clin
Immunol, which was ranked 20
th based on AIS and 14
th based on
IF.
Using ES values resulted in large changes in the rank order of
the selected journals. While the N Engl J Med retained the top spot,
J Neurosci took over 2
nd spot on the list, followed by Circulation,
Lancet and JAMA. In general, journals that published a lot of
Table 1. Journal Rankings Based On Their 2008 Eigenfactor, Impact Factor and the Article Influence Score.
Journal Eigenfactor Score Article Influence Score Impact Factor
N Engl J Med 0.68060 (1) 18.764 (1) 50.017 (1)
J Neurosci 0.52199 (2) 3.544 (11) 7.452 (20)
Circulation 0.48312 (3) 4.794 (5) 14.595 (6)
Lancet 0.41221 (4) 9.953 (3) 28.409 (3)
JAMA 0.38132 (5) 11.153 (2) 31.718 (2)
J Clin Oncol 0.34752 (6) 4.164 (7) 17.157 (4)
J Am Coll Cardiol 0.22767 (7) 3.727 (10) 11.438 (10)
J Clin Endocr Metab 0.16459 (8) 1.803 (27) 6.325 (27)
Gastroenterology 0.15356 (9) 3.913 (9) 12.591 (9)
Diabetes 0.14843 (10) 2.989 (17) 8.398 (18)
Diabetes Care 0.13757 (11) 2.508 (19) 7.349 (21)
Clin Inf Dis 0.13735 (12) 2.345 (21) 8.266 (19)
Art Rheum/Ar C Res 0.12799 (13) 2.062 (25) 6.787 (24)
J Infect Dis 0.12043 (14) 2.064 (24) 5.682 (29)
Am J Resp Crit Care Med 0.11875 (15) 3.125 (15) 9.792 (13)
Hepatology 0.11722 (16) 3.363 (13) 11.355 (11)
Chest 0.11173 (17) 1.516 (30) 5.154 (31)
J Natl Cancer I 0.09924 (18) 5.791 (4) 14.933 (5)
Brain 0.09868 (19) 3.527 (12) 9.603 (16)
Eur Heart J 0.09764 (20) 3.010 (16) 8.917 (17)
J Allergy Clin Immunol 0.09561 (21) 2.488 (20) 9.773 (14)
Crit Care Med 0.08298 (22) 1.852 (26) 6.594 (25)
Ann Neurol 0.08000 (23) 3.338 (14) 9.935 (12)
Gut 0.07273 (24) 2.551 (18) 9.766 (15)
Eur Resp J 0.06172 (25) 1.775 (29) 5.545 (30)
J Bone Miner Res 0.06006 (26) 2.295 (22) 6.443 (26)
Ann Rheum Dis 0.05717 (27) 1.802 (28) 7.188 (22)
Thorax 0.04291 (28) 2.280 (23) 7.069 (23)
Intens Care Med 0.03599 (29) 1.214 (33) 5.055 (32)
Lancet Oncol 0.03510 (30) 3.947 (8) 13.283 (7)
Rheumatology 0.03438 (31) 1.188 (34) 4.136 (34)
Lancet Infect Dis 0.03202 (32) 4.689 (6) 13.165 (8)
Allergy 0.02893 (33) 1.355 (31) 6.204 (28)
Clin Exp Allergy 0.02779 (34) 1.150 (35) 3.556 (35)
Critical Care 0.02355 (35) 1.346 (32) 4.553 (33)
Data presented as value (column rank).
doi:10.1371/journal.pone.0010204.t001
Impact Factor
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volumes of papers (figure 1). For instance, Lancet Oncol, which was
ranked 8
th on the AIS and 7
th on the IF lists, was ranked only 30
th
on the ES list. On the other hand, J Clin Endocr Metab, which
ranked 27
th on both the AIS and IF lists, was ranked 8
th on the ES
list.
Both the IF and CI correlated significantly with the 2008 ES
values (p value for both ,.0001). The partial square value for IF
was 0.5721 and that for CI was 0.3678. Thus, collectively, they
accounted for 94% of the variance in the 2008 ES values. As the
IF values increased so did the ES values (See figure 1A and 1B). In
general, however, journals with a high number of citable items
displayed higher ES values than those that had a small number of
citable items.
Trends in IF, ES, AIS, and CI Between 2001 and 2008
Since 2001, the IF of 77% (27/35) of the journals included this
analysis increased significantly (Table 2). Only J Neurosci experi-
enced a significant decline in IF. In the remaining journals, the IF
did not change significantly over time. In contrast, only 51% (=18/
35) of the journals increased their ES values over the 8 years, while
26% (=9/35) of the journals experienced a decline in their EF
values (table 3). The discordance between the temporal trends in IF
andESwas largelydrivenbythetemporalchangesinthe numberof
citable items published by each of the journals (see figure 2A). In
20% of the journals, the number of citable items increased and in
another 20% the number of citable items decreased over time. In
the remaining 60%, the number of citable items did not change
significantly (Table 4; figure 2A). In general, as the number of
citable items decreased, the IF of the journals increased, though this
relationship did not reach statistical significance (p=0.132) largely
due to the extreme effects of the New England Journal of Medicine,
whose IF score increased by 21 in the absence of any significant
changes in the number of citable items over the 8 years of the study.
The removal of the New England Journal of Medicine from this analysis,
however, led to a significant relationship between the temporal
trends in CI and IF (figure 2B; p=0.05). There were journals whose
IF score and the number citable items both increased during this
periodof time (seeTables2 and 4).These included the European Heart
Journal, Brain, Rheumatology,a n dCritical Care. On the other hand,
journals such as Intensive Care Medicine,t h eJournal of American College of
Cardiology, Diabetes Care, the Journal of Infectious Diseases, Hepatology,
Annals of Rheumatic Diseases, Chest, Allergy,t h eEuropean Respiratory
Journal, Critical Care Medicine, Lancet Oncology, Clinical Infectious Diseases,
the Journal of Clinical Oncology, Lancet Infectious Diseases, the Journal of
Allergy and Clinical Immunology, and the New England Journal of Medicine
increased their IF without significantly changing the number of
citable items that were published per year. Conversely, a few
Figure 1. The Relationship Between Impact Factor (IF) and Eigenvalue Score (ES) In 2008. The area of the circles is proportional to the
number of citable items published in 2008. The area of the dotted line is expanded in figure 1B. R
2=0.5721; p,0.0001.
doi:10.1371/journal.pone.0010204.g001
Impact Factor
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and Critical Care Medicine, the Journal of the American Medical Association,
Gut, and Thorax increased their IF but at the same time decreased the
number of citable items published per year. Interestingly, some
journals such as the Journal of Bone and Mineral Research and Journal of
National Cancer Institute reduced the number of citable items without
experiencing an increase in their IF. The temporal trends in AIS
were similar to those of IF. 66% of the journals experienced an
increase in AIS, while 6% experienced a decline (Table 5).
Discussion
There is no universally accepted metric for assessing the
‘‘quality’’ and ‘‘influence’’ of journals to the scientific community.
In the Journal Citation Reports, ISI provides several attributes for
assessing quality including total citations, IF, ES, and AIS. Of
these the most widely used metric is the IF. However, the major
shortcoming of IF is that it is sensitive to the number of original
research papers published per year. Because in general review
papers and guidelines have a higher citation index than that for
original papers, by publishing fewer original papers (and more
review papers), journals can increase their IF. Paradoxically,
however, because original research is the primary engine for
generating new scientific knowledge (or validating existing
knowledge), by reducing the publication rate of research articles,
journals’ influence on the scientific discourse of their discipline
may decrease. ES is an attempt to capture the ‘‘influence’’ of
medical journals on the scientific discourse generated in their
Table 2. Temporal Trends in the Impact Factor of Common Medical Journals Between 2001 and 2008.
Journal 2001 2002 2003 2004 2005 2006 2007 2008 P trend
Allergy 2.852 3.666 3.161 3.496 4.120 5.334 5.014 6.204 0.0006q
Am J Resp Crit Care Med 5.956 6.567 8.876 8.123 8.689 9.091 9.074 9.792 0.0083q
Ann Neurol 8.481 8.603 7.717 8.097 7.571 8.051 8.813 9.935 0.2575
Ann Rheum Dis 3.188 3.593 3.827 3.916 6.956 5.767 6.411 7.188 0.0021q
Art Rheum/Ar C Res 7.389 7.379 7.190 7.414 7.421 7.751 7.677 6.787 0.8108
Brain 7.407 7.122 7.967 8.201 7.535 7.617 8.568 9.603 0.0265q
Chest 2.480 2.969 3.264 3.118 4.008 3.924 4.143 5.154 0.0008q
Circulation 10.517 10.255 11.164 12.563 11.632 10.940 12.755 14.595 0.0174q
Clin Exp Allergy 3.826 3.721 3.176 3.069 3.553 3.668 3.729 3.556 0.9845
Clin Inf Dis 3.545 4.750 5.393 5.594 6.510 6.186 6.750 8.266 0.0002q
Crit Care Med 3.486 3.361 4.195 4.182 5.077 6.599 6.283 6.594 0.0003q
Critical Care 0.701 0.876 1.911 3.214 2.932 3.116 3.834 4.553 0.0002q
Diabetes 7.700 8.256 8.298 8.848 8.028 7.955 8.261 8.398 0.5307
Diabetes Care 5.404 5.477 7.501 7.071 7.844 7.912 7.851 7.349 0.0239q
Eur Heart J 5.153 6.131 5.997 6.247 7.341 7.286 7.924 8.917 ,.0001q
Eur Resp J 2.989 2.931 2.999 3.096 3.947 5.076 5.349 5.545 0.0006q
Gastroenterology 13.020 13.440 12.718 13.092 12.386 12.457 11.673 12.591 0.0427Q
Gut 6.170 6.323 5.883 6.601 7.692 9.002 10.015 9.766 0.0008q
Hepatology 8.096 9.825 9.503 10.416 9.792 10.446 10.734 11.355 0.0038q
Intens Care Med 2.314 2.041 2.971 3.304 3.724 4.406 4.623 5.055 ,.0001q
J Allergy Clin Immunol 5.506 6.282 6.831 7.205 7.667 8.829 8.115 9.773 0.0001q
J Am Coll Cardiol 6.374 6.278 7.599 9.133 9.200 9.701 11.054 11.438 ,.0001q
J Bone Miner Res 6.230 6.329 6.225 5.436 6.527 6.635 6.004 6.443 0.6879
J Clin Endocr Metab 5.160 5.199 5.873 5.778 6.020 5.799 5.493 6.325 0.0523
J Clin Oncol 8.530 9.868 10.864 9.835 11.810 13.598 15.484 17.157 0.0002q
J Infect Dis 4.910 4.857 4.481 4.943 4.953 5.363 6.035 5.682 0.0158q
J Natl Cancer I 14.240 14.500 13.844 13.856 15.171 15.271 15.678 14.933 0.0538
J Neurosci 8.178 8.045 8.306 7.907 7.506 7.453 7.490 7.452 0.0037Q
JAMA 17.569 16.586 21.455 24.831 23.494 23.175 25.547 31.718 0.0021q
Lancet 13.251 15.397 18.316 21.713 23.878 25.800 28.638 28.409 ,.0001q
Lancet Infect Dis n/a
1 n/a
1 n/a
1 10.788 10.008 11.808 12.058 13.165 0.0002q
Lancet Oncol n/a
1 n/a
1 7.411 8.794 9.608 10.119 12.247 13.283 0.0003q
N Engl J Med 29.065 31.736 34.833 38.570 44.016 51.296 52.589 50.017 0.0001q
Rheumatology 3.062 3.251 3.760 4.102 4.226 4.052 4.045 4.136 0.0109q
Thorax 4.090 4.078 4.188 5.040 6.150 6.064 6.226 7.069 0.0002q
Significant increase over time denoted by (q), while significant decrease is denoted (Q).
1n/a = not available.
doi:10.1371/journal.pone.0010204.t002
Impact Factor
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years most medical journals (77% evaluated in this study) have
increased their IF. However, 26% of the journals have
experienced a paradoxical reduction in their ES during this
period of time, associated with a decrease in the number of citable
items that were published per year in these journals. Interestingly
and provocatively, many journals that fall into this category were
those with a very high IF such as the Lancet, Circulation, American
Journal of Respiratory and Critical Care Medicine and the Journal of the
American Medical Association. Notable exceptions in this category
were the New England Journal of Medicine and the Journal of Clinical
Oncology, both of which experienced a dramatic increase in their IF
without any significant changes in their publication rate of citable
items. We also found that there were journals which increased
their IF, ES, as well as the number of citable items published per
year. These included the European Heart Journal, and Critical Care.
Other journals have increased or maintained their IF without
decreasing the number of papers published per year or sacrificing
their ES values over time. These data indicate that IF and ES in
particular can produce dissimilar results and thus highlight the
importance of using multiple rather than just one metric in
assessing the performance of journals and the impact and influence
they have on their respective fields of study.
Our data are consistent with those of Chew et al [20], who
showed that the IF of the seven top-ranked general medical
journals rose considerably between 1994 and 2005 but the
Table 3. Temporal Trends in Eigenfactor Score of Common Medical Journals Between 2001 and 2008.
Journal 2001 2002 2003 2004 2005 2006 2007 2008 P trend
Allergy 0.07282 0.080834 0.075831 0.076492 0.078997 0.085935 0.02562 0.02893 0.0876
Am J Resp Crit Care Med 0.15806 0.17425 0.17693 0.16138 0.15427 0.14639 0.12449 0.11875 0.0065Q
Ann Neurol 0.10808 0.10385 0.10094 0.098948 0.091732 0.092764 0.08541 0.08000 ,.0001Q
Ann Rheum Dis 0.018389 0.019886 0.024583 0.030932 0.040236 0.046286 0.05478 0.05717 ,.0001q
Art Rheum/Ar C Res 0.08375 0.08367 0.09978 0.1111 0.1227 0.12685 0.13066 0.12799 0.0003q
Brain 0.01939 0.016637 0.017696 0.01884 0.0155 0.015057 0.09959 0.09868 0.0373q
Chest 0.084284 0.089413 0.097728 0.098228 0.10029 0.1102 0.10961 0.11173 ,.0001q
Circulation 0.48859 0.50912 0.5136 0.55557 0.55648 0.54769 0.53421 0.48312 0.6521
Clin Exp Allergy 0.041638 0.033118 0.032557 0.029458 0.031495 0.029831 0.0284 0.02779 0.0040Q
Clin Inf Dis 0.09477 0.10738 0.11542 0.11965 0.14562 0.14695 0.13481 0.13735 0.0065q
Crit Care Med 0.053328 0.059861 0.06925 0.07191 0.075306 0.074332 0.07932 0.08298 0.0002q
Critical Care 0.000450 0.000930 0.001826 0.003928 0.005918 0.009211 0.01766 0.02355 0.0163q
Diabetes 0.12751 0.13088 0.14085 0.15923 0.15884 0.16705 0.16425 0.14843 0.0314q
Diabetes Care 0.0747 0.088212 0.088662 0.09683 0.11157 0.12342 0.13564 0.13757 ,.0001q
Eur Heart J 0.043836 0.048415 0.049693 0.0486 0.059156 0.070785 0.08836 0.09764 0.0007q
Eur Resp J 0.058554 0.057278 0.051405 0.051253 0.052220 0.062227 0.06297 0.06172 0.2168
Gastroenterology 0.1629 0.16054 0.15203 0.14565 0.15427 0.15842 0.15861 0.15356 0.5501
Gut 0.071954 0.069639 0.070522 0.072297 0.070967 0.077763 0.08003 0.07273 0.1039
Hepatology 0.12885 0.13153 0.13122 0.12194 0.11457 0.11437 0.10952 0.11722 0.0071Q
Intens Care Med 0.021169 0.020998 0.026719 0.026049 0.032777 0.030637 0.03164 0.03599 0.0005q
J Allergy Clin Immunol 0.07282 0.080834 0.075831 0.076492 0.078997 0.085935 0.08087 0.09561 0.0203q
J Am Coll Cardiol 0.17946 0.17849 0.19083 0.20115 0.20778 0.22425 0.24561 0.22767 0.0005q
J Bone Miner Res 0.074053 0.074098 0.071383 0.063249 0.069853 0.064298 0.05845 0.06006 0.0026Q
J Clin Endocr Metab 0.14938 0.15631 0.17443 0.18105 0.19196 0.19941 0.17641 0.16459 0.2057
J Clin Oncol 0.16178 0.1829 0.21401 0.22286 0.2357 0.28292 0.32292 0.34752 ,.0001q
J Infect Dis 0.15884 0.15267 0.14252 0.14191 0.14062 0.14092 0.12948 0.12043 0.0004Q
J Natl Cancer I 0.12546 0.12639 0.12517 0.11642 0.11327 0.10658 0.10638 0.09924 ,.0001Q
J Neurosci 0.53382 0.54054 0.53744 0.5374 0.53002 0.50843 0.48824 0.52199 0.0495Q
JAMA 0.37474 0.39978 0.43187 0.44731 0.44905 0.45493 0.41748 0.38132 0.6510
Lancet 0.52281 0.53936 0.5347 0.54342 0.51354 0.5002 0.45171 0.41221 0.0093Q
Lancet Infect Dis n/a
1 n/a
1 n/a
1 0.015212 0.021729 0.028966 0.03367 0.03202 0.0204q
Lancet Oncol n/a
1 n/a
1 0.008829 0.015841 0.01954 0.023433 0.03318 0.03510 0.0002q
N Engl J Med 0.6099 0.63452 0.65826 0.69058 0.68049 0.7183 0.69405 0.68060 0.0165q
Rheumatology 0.0085104 0.0086894 0.0079648 0.025789 0.012345 0.01346 0.03424 0.03438 0.0191q
Thorax 0.042666 0.043209 0.039287 0.04243 0.042654 0.046807 0.04395 0.04291 0.3280
1n/a = not available.
Significant increase over time denoted by (q), while significant decrease is denoted (Q).
doi:10.1371/journal.pone.0010204.t003
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or remained constant. Our data are also consistent with those by
Bollen et al, who showed that the concept of scientific impact is
multi-dimensional that cannot be adequately captured by IF alone
[21] and that both usage and citation based measures are needed
to understand the scientific impact of journals. It should also be
noted in our analysis that although IF and AIS values are
calculated differently, they nonetheless produced similar rank
order of journals, suggesting that the weighting system of AIS does
not significantly modify the performance status of the journals.
The major discrepancies occurred only when the denominator of
AIS was removed (yielding ES values), which highlights the
importance of quantity of publications in the determination of
scientific impact of journals.
There are important implications for these data. Firstly, it is
essential that authors take into account not only the IF of journals
on deciding where to send their paper but also the ES, as journals
with high IF but low ES may have low readership and have little
influence on their respective field, although in general papers that
are highly accessed and viewed are cited more frequently than
those that have limited access [22,23,24]. Secondly, IF must be
viewed in the context of other metrics such as ES and AIS, which
takes into account not only the quantity but also the quality of the
citations. Thirdly, the rise of the journal IF over the past decade
likely reflects the increase in the citation rate of papers published in
these journals. However, it is possible that in some journals, the
rise in their IF may in part reflect a reduction in the number of
original articles published per year. The potential paradox is that
by doing so these journals may be limiting their influence. Thus, as
with individual researchers, journals should use IF in conjunction
with other metrics such as ES in assessing the relevance and
‘‘impact’’ of their journals in their respective field.
Figure 2. The Relationship of Changes in Citable Items Between 2001 and 2008 to Changes in Eigenfactor Score and Impact Factor
Between 2001 and 2008. R
2=0.1957; p=0.0099 for the relationship between changes in citable items and changes in Eigenfactor score and
R
2=0.1216; p=0.0505* for the relationship between changes in citable items and changes in the impact factor. *The New England Journal of Medicine
was excluded from the regression analysis, as it was an extreme outlier.
doi:10.1371/journal.pone.0010204.g002
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PLoS ONE | www.plosone.org 7 April 2010 | Volume 5 | Issue 4 | e10204There were limitations to this study. Firstly, ES was used as a
surrogate for the ‘‘influence’’ of journals. However, this metric
has never been fully validated for this outcome. In the same
vein, IF has never been fully validated as measure of ‘‘quality’’,
though it is widely used in this fashion. Secondly, there are other
conventional metrics of journal quality such as immediacy
index, citation half-life, or PageRank based metrics such as
SCImago journal rank indicator[25] that were not considered in
the present analysis. Thirdly, an important aspect of under-
standing the influence of journals is to determine the size and
make-up of the readership, which was not done in the present
study. Some [22,23,24] but not all [26]studies suggest that
p a p e r st h a ta r ev i e w e dm o r ef r e q u ently receive higher citation
rates than those that are accessed infrequently. Fourthly, we did
not determine the reasons for the rise and fall of IF, ES and
citable items in these journals. A previous study suggested that
the temporal increases in IF for certain journals may reflect
several factors including active recruitment of ‘‘high-impact’’
papers by journal editors, acceleration of the review and
publication process, early on-line publication of accepted
articles, media promotion of articles and journals, and the
increase in the number of journals included in the ISI database
[20]. The reasons for the fall in the citable items for certain
journals are also unclear. Some explanations include journals
becoming more selective of the articles that they were accepting,
and re-design of journals leading to fewer pages [20]. Whatever
Table 4. Temporal Trends in Citable Items of Common Medical Journals Between 2001 and 2008.
Journal 2001 2002 2003 2004 2005 2006 2007 2008 P trend
Allergy 201 207 184 175 211 205 188 188 0.6392
Am J Resp Crit Care Med 569 446 380 330 375 330 299 309 0.0059Q
Ann Neurol 220 232 255 237 251 204 134 169 0.0626
Ann Rheum Dis 230 283 339 377 364 290 295 302 0.5571
Art Rheum/Ar C Res 346 478 513 597 505 559 626 640 0.0053q
Brain 202 196 227 235 256 276 268 275 0.0003q
Chest 720 729 704 654 915 492 560 388 0.0912
Circulation 1029 995 1084 1129 980 682 670 607 0.0108q
Clin Exp Allergy 215 239 226 264 215 180 205 201 0.1856
Clin Inf Dis 611 513 572 431 564 490 425 517 0.1732
Crit Care Med 397 474 476 363 313 468 379 445 0.8089
Critical Care 52 59 66 125 140 116 176 177 0.0005q
Diabetes 420 556 405 497 478 481 379 391 0.3059
Diabetes Care 301 99 467 474 482 460 591 423 0.0850
Eur Heart J 187 186 211 250 312 360 330 296 0.0060q
Eur Resp J 284 403 402 294 285 306 285 343 0.5201
Gastroenterology 295 361 316 376 349 361 368 353 0.1338
Gut 266 352 307 280 243 223 255 193 0.0292Q
Hepatology 329 363 296 319 284 318 355 384 0.4380
Intens Care Med 267 163 325 294 213 246 259 260 0.8746
J Allergy Clin Immunol 329 294 325 348 169 338 350 347 0.7633
J Am Coll Cardiol 543 529 506 591 561 591 506 462 0.4743
J Bone Miner Res 261 259 262 208 229 232 229 212 0.0305Q
J Clin Endocr Metab 867 813 850 868 950 741 709 664 0.0712
J Clin Oncol 511 554 643 595 1021 734 707 766 0.1221
J Infect Dis 533 585 548 581 561 440 502 494 0.1091
J Natl Cancer I 165 156 157 159 158 156 143 145 0.0103Q
J Neurosci 1083 1194 1288 1233 1232 1415 1476 1438 0.0016q
JAMA 389 383 377 351 380 267 229 225 0.0025Q
Lancet 569 522 553 415 360 301 305 289 0.0003Q
Lancet Infect Dis n/a
1 n/a
1 n/a
1 58 58 62 65 50 0.6821
Lancet Oncol n/a
1 n/a
1 94 89 87 91 93 105 0.2091
N Engl J Med 375 378 366 316 308 303 343 356 0.2251
Rheumatology 177 190 221 240 264 275 305 320 ,.0001q
Thorax 182 207 198 195 165 163 155 163 0.0210Q
1n/a = not available.
Significant increase over time denoted by (q), while significant decrease is denoted (Q).
doi:10.1371/journal.pone.0010204.t004
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PLoS ONE | www.plosone.org 8 April 2010 | Volume 5 | Issue 4 | e10204the reason, by reducing the citable items, some journals may
have (intentionally or unintentionally) increased their IF.
In summary, the present study indicates that IF and ES produce
similar rank order of medical journals; however, some important
discordances occur. In general, journals that publish a lot of papers
have higher ES values than would be expected for their IF.
Conversely, journals that publish a small volume of papers have
lower ES values than expected for their IF. Some journals have
increased their IF and at the same time reduced the number of
papers that they publish per year, which may have reduced their
influence on the field. Medical journals should carefully balance
the important of IF and ES in their editorial composition of the
quality and quantity of articles published.
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